Rutgers yana ba da bege ga sabon magani don raunin kashin baya
Rutgers yana ba da bege ga sabon magani don raunin kashin baya
Anonim

Masu bincike na Rutgers sun haɓaka sabon sabon magani wanda zai iya taimakawa rage lalacewar jijiya a cikin raunin kashin baya, inganta warkar da nama da kuma rage jin zafi.

Bayan raunin kashin baya an sami karuwar samar da furotin (RhoA) wanda ke toshe farfadowa na ƙwayoyin jijiya waɗanda ke ɗauke da sigina tare da kashin baya kuma ya hana nama mai rauni daga warkarwa.

Masana kimiyya a W.M. Keck Center for Hadin baki Neuroscience da Quark Pharmaceuticals Inc. sun ɓullo da wani chemically hada siRNA kwayoyin cewa rage-rage samar da RhoA gina jiki a lokacin da gudanar da kashin baya da kuma damar farfadowa daga cikin jijiya Kwayoyin.

"Yana da ban sha'awa saboda wannan maganin da ba zai iya yin amfani da shi ba zai iya zaɓar wanda ya ji rauni kuma ya inganta warkarwa da kuma rage ciwo," in ji Martin Grumet, mataimakin darektan Cibiyar Keck kuma babban marubucin wani binciken da aka buga a kwanan nan a cikin Journal of Neurotrauma.

Ciwon neuropathic, wanda kuma aka sani da ciwon fatalwa wanda ke faruwa a sakamakon raunin kashin baya yana da alaƙa da haɓakar haɓakar RhoA. Lokacin da masu bincike suka yi allurar da aka haɗa da sinadarai a cikin kashin baya na berayen dakin gwaje-gwaje tare da raunin kashin baya ta hanyar amfani da hanya mai kama da bugun kashin baya, an sami ci gaba gabaɗaya wajen warkar da nama da farfadowa.

Fiye da mutane 250,000 a Amurka suna rayuwa tare da raunin kashin baya kuma a halin yanzu babu wata hanyar da za a iya mayar da lalacewa. Ba a yarda da wani magani don farkon maganin raunin kashin baya ba a cikin shekaru goma. Dangane da wannan bincike na haɗin gwiwa, Quark Pharmaceuticals, Inc yanzu yana da shirin ci gaba na miyagun ƙwayoyi don maganin cututtuka na kashin baya da ciwon neuropathic. Wannan sabon binciken yana samun goyan bayan tallafi daga Hukumar New Jersey don Binciken Kaya da Quark.

Shahararren taken